Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps

NCT05598424 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT05598424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05598424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
Lead sponsor
Beijing Tongren Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 22, 2022
Completion date
November 1, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps, glucocorticoids